Sinopharm
1099.HK
#1870
Rank
A$13.77 B
Marketcap
$4.42
Share price
-0.23%
Change (1 day)
24.01%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Market capitalization of Sinopharm (1099.HK)

Market cap: A$13.77 Billion

As of December 2024 Sinopharm has a market cap of A$13.77 Billion. This makes Sinopharm the world's 1870th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sinopharm from 2009 to 2024

End of year Market Cap

Year Marketcap Change
2024A$13.77 B14.87%
2023A$11.99 B2.74%
2022A$11.67 B24.7%
2021A$9.36 B-0.21%
2020A$9.38 B-39.49%
2019A$15.50 B-12.51%
2018A$17.72 B15.64%
2017A$15.32 B-3.1%
2016A$15.81 B3.77%
2015A$15.24 B27.37%
2014A$11.96 B44.83%
2013A$8.26 B14.22%
2012A$7.23 B28.58%
2011A$5.62 B-27.54%
2010A$7.76 B-13.33%
2009A$8.95 B